Business Wire

Aviva Bio Announces FDA Guidance on Development Pathway for Women’s Testosterone Therapy.

In its feedback, the FDA acknowledged the potential breast cancer risk associated with T use in women—a central safety issue that has historically limited the development of a T therapy for women.
Yahoo Finance

Aviva Bio Announces FDA Guidance on Development Pathway for Women’s Testosterone Therapy and New Evidence of a Reduced Risk of Breast Cancer Cell Proliferation for AVA-291

CONCORD, Mass., January 26, 2026--(BUSINESS WIRE)--Aviva Bio, a new biotechnology company focused on rewriting the narrative around hormone-based medicine, announced today it has received formal ...
Medindia

Why Women Experience Chronic Pain Longer: The Role of Testosterone

A specific subset of immune cells driven by testosterone resolves pain faster in men, explaining why women are more likely to ...

Is your testosterone low? 5 symptoms every man should watch for

Low testosterone can cause fatigue, low libido, mood changes, muscle loss, and bone weakness.
Rutland Herald

Aviva Bio Announces FDA Guidance on Development Pathway for Women’s Testosterone Therapy and New Evidence of a Reduced Risk of Breast Cancer Cell Proliferation for AVA-291

Aviva Bio, a new biotechnology company focused on rewriting the narrative around hormone-based medicine, announced today it has received formal feedback from the FDA in a Type B meeting regarding the ...